{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:05:22Z","timestamp":1790705122579,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ejphar.2018.04.007","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T12:14:27Z","timestamp":1523362467000},"page":"85-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Vascular and molecular pharmacology of the metabolically stable CGRP analogue, SAX"],"prefix":"10.1016","volume":"829","author":[{"given":"Majid","family":"Sheykhzade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Abdolalizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Koole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8687-6094","authenticated-orcid":false,"given":"Darryl Scott","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Dreisig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Ellinor","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balsam Kadri","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus","family":"Dreier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jais Oliver","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen Lykke","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Edvinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Wootten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Sams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.04.007_bib1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.2994212","article-title":"Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide","volume":"229","author":"Amara","year":"1985","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ejphar.2018.04.007_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/CIRCULATIONAHA.117.028388","article-title":"A Novel alpha-calcitonin gene-related peptide analogue protects against end-organ damage in experimental hypertension, cardiac hypertrophy and heart failure","volume":"136","author":"Aubdool","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2018.04.007_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/313054a0","article-title":"Calcitonin gene-related peptide is a potent vasodilator","volume":"313","author":"Brain","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2018.04.007_bib4","first-page":"E331","article-title":"Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37)","volume":"256","author":"Chiba","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2018.04.007_bib5","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1111\/bph.12856","article-title":"Experimental design and analysis and their reporting: new guidance for publication in BJP","volume":"172","author":"Curtis","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.04.007_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-3940(85)90166-1","article-title":"Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat","volume":"58","author":"Edvinsson","year":"1985","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2018.04.007_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1468-2982.1994.1402088.x","article-title":"Demonstration of neuropeptide containing nerves and vasomotor responses to perivascular peptides in human cerebral arteries","volume":"14","author":"Edvinsson","year":"1994","journal-title":"Cephalalgia: Int. J. Headache"},{"key":"10.1016\/j.ejphar.2018.04.007_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of migraine: a disorder of sensory processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2018.04.007_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bcp.2017.03.018","article-title":"Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1","volume":"136","author":"Hager","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.04.007_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1389203033380313","article-title":"Neuropeptide conversion to bioactive fragments--an important pathway in neuromodulation","volume":"4","author":"Hallberg","year":"2003","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ejphar.2018.04.007_bib11","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1124\/mol.104.008615","article-title":"Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes","volume":"67","author":"Hay","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.04.007_bib12","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1124\/mol.106.027953","volume":"70","author":"Hay","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.04.007_bib13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.bjp.0705472","article-title":"CL\/RAMP2 and CL\/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS","volume":"140","author":"Hay","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.04.007_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","article-title":"CGRP and its receptors provide new insights into migraine pathophysiology","volume":"6","author":"Ho","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2018.04.007_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1748-1716.1983.tb07178.x","article-title":"Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels","volume":"117","author":"Hogestatt","year":"1983","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ejphar.2018.04.007_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fendo.2012.00135","article-title":"Role of calcitonin gene-related peptide in cerebral vasospasm, and as a therapeutic approach to subarachnoid hemorrhage","volume":"3","author":"Kokkoris","year":"2012","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2018.04.007_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0167-0115(85)90013-8","article-title":"Infusion of a novel peptide, calcitonin gene-related peptide (CGRP) in man. Pharmacokinetics and effects on gastric acid secretion and on gastrointestinal hormones","volume":"10","author":"Kraenzlin","year":"1985","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2018.04.007_bib18","series-title":"The Pharmacology of Functional, Biochemical and Recombinant Receptor Systems","first-page":"313","article-title":"The assembly of recombinant signalling systems and their use in investigating signalling dynamics","author":"Lanier","year":"2012"},{"key":"10.1016\/j.ejphar.2018.04.007_bib19","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2018.04.007_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/mol.107.037630","article-title":"Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors","volume":"72","author":"May","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.04.007_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2018.04.007_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2009.11.076","article-title":"Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74","volume":"391","author":"Miller","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2018.04.007_bib23","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1074\/jbc.M107384200","article-title":"Functional expression of heteromeric calcitonin gene-related peptide and adrenomedullin receptors in yeast","volume":"277","author":"Miret","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.04.007_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","article-title":"Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats","volume":"41","author":"Mulvany","year":"1977","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2018.04.007_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejphar.2016.01.003","article-title":"Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1","volume":"773","author":"Nilsson","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.04.007_bib26","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1002\/jps.23648","article-title":"In vitro protein binding of liraglutide in human plasma determined by reiterated stepwise equilibrium dialysis","volume":"102","author":"Plum","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2018.04.007_bib27","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1074\/jbc.M305332200","article-title":"Intermedin is a calcitonin\/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor\/receptor activity-modifying protein receptor complexes","volume":"279","author":"Roh","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.04.007_bib28","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2018.04.007_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1196\/annals.1317.076","article-title":"Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs","volume":"1070","author":"Sexton","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2018.04.007_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2017.02.001","article-title":"Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries","author":"Sheykhzade","year":"2017","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.04.007_bib31","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.bjp.0705967","article-title":"Noncompetitive antagonism of BIBN4096BS on CGRP-induced responses in human subcutaneous arteries","volume":"143","author":"Sheykhzade","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.04.007_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1042\/bj0900293","article-title":"The separation of synaptic vesicles from nerve-ending particles ('synaptosomes')","volume":"90","author":"Whittaker","year":"1964","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2018.04.007_bib33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3892\/br.2016.658","article-title":"Calcitonin gene-related peptide protects rats from cerebral ischemia\/reperfusion injury via a mechanism of action in the MAPK pathway","volume":"4","author":"Yang","year":"2016","journal-title":"Biomed. rep."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918302176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918302176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T11:24:13Z","timestamp":1534937053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918302176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":33,"alternative-id":["S0014299918302176"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.04.007","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular and molecular pharmacology of the metabolically stable CGRP analogue, SAX","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}